Dr. William Hunter, M.D. is a member of CorInnova's Advisory Board. Dr. Hunter is President and CEO of Cardiome, a specialty pharma company. Prior to Cardiome, Dr. Hunter co-founded Angiotech in 1992 and became CEO in 1997 when Angiotech was a venture-stage, private, pre-clinical company with less than 50 employees. He led Angiotech through three rounds of private equity financing, the Company's IPO, over $1 billion in equity and debt financings, a debt restructuring and eight separate corporate acquisitions. During that time, Angiotech grew to become a profitable, diversified, healthcare company with over 1,400 employees, 12 facilities in five countries and worldwide annual revenues exceeding $250 million. Dr. Hunter has over 200 patents and patent applications to his name and products in which he was an inventor or co-inventor, including the TAXUS Drug-Eluting Coronary Stent.